OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells is a paramount challenge with the biopharmaceutical industry. Various strategies have been employed enhance antibody titer, such as process parameter optimization, genetic engineering, and the use of perfusion technologies. Fine-tuning culture conditions play